Huntington’s disease, which causes involuntary motions and dementia and is deadly, has no cure. For the first time, UC Riverside researchers have demonstrated that they can limit its spread in flies and worms, paving the way for human therapy.
The process by which genetic information in cells is transferred from DNA to RNA and ultimately to proteins is critical to comprehending these advances. DNA is made up of nucleotides such as adenine (A), thymine (T), guanine (G), and cytosine (C). What biological instructions are present in a strand of DNA are determined by the arrangement of these nucleotides.
Some DNA nucleotides repeat themselves on sometimes, lengthening the DNA strand. This expansion occurs in Huntington’s disease with three nucleotides, cytosine-adenine-guanine, or CAG.
Expansion into an unusually large number of repetitive CAG sequences of DNA is linked to an earlier onset and severity of Huntington’s disease symptoms. Similar findings have been made for a variety of different neurodegenerative illnesses.
When these DNA repeats are translated into RNA, an unintended consequence occurs. The excess RNA accumulation is chemically modified by the cell. Wang and his colleagues discovered that the changed RNA plays an important function in neurodegeneration.
“We are the first to discover that methylation, a type of chemical modification, occurs more frequently with extra repeats in RNA.” Then we detect aberrant protein distribution and accumulation in cells,” said Yinsheng Wang, renowned UCR professor of chemistry. “In other words, methylation converts an important cellular protein into waste.”
These findings corroborate previous discoveries for the same protein in Huntington’s disease, ALS, and frontotemporal dementia patients’ brain tissues. Longer RNA repeats indicate a higher modification rate, which results in more protein waste and worsens illness.
“Even healthy people have up to 34 CAG repeats on a particular gene, the HTT gene,” Wang told me. However, due to environmental or genetic causes, there might be as many as 100 CAG repeats in the cells of people with Huntington’s disease.”
Long, repeating RNA sequences can produce an overabundance of protein in cells, resulting in “cellular trash,” which is harmful.
A recent Nature journal paper describes how RNA methylation on CAG repeats plays a role in the complicated system that underpins Huntington’s disease. The article also describes how the researchers used a protein that eliminates methylation to slow the course of disease in worms and fruit flies and to lengthen the lifetime of flies.
There is no way to cure or even delay the progression of Huntington illness at the moment. Medications are commonly prescribed by doctors to alleviate certain ailments. While this is not a cure, it does indicate the possibility of an effective therapy when none previously existed.
The study team, which includes UCR professors Weifeng Gu, X. William Yang, and Nancy M. Bonini, is now looking for tiny compounds that can suppress methylation and form the basis of a Huntington’s therapy.
Because RNA repeats are seen in other deadly, degenerative diseases, such as ALS and some types of spinocerebellar ataxia, the door to therapy for these other fatal, degenerative diseases is now open.
“We don’t think the mechanisms we studied are the only ones that contribute to Huntington’s,” said Wang. “However, we have shown that by targeting them we can reduce the disease in model organisms, which could lead to longer, better lives for those who suffer from this and potentially other diseases as well.”
more recommended stories
-
Air Pollution Hurts Brain Health in Just 4 Hours
Air Pollution Blurs the Mind, Impairs.
-
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders
Urgent treatment solutions are needed for.
-
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences Division
The High-Level Meeting on antimicrobial resistance.
-
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences Division
The installation was commissioned to mark.
-
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences Division
Scientists at the University of Oxford,.
-
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences Division
Antimicrobial resistance (AMR) threatens the foundation.
-
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences Division
The TyVOID study, published in the Lancet, measured the.
-
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences Division
The research addresses the long-recognized poor.
-
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences Division
Only 30 prizes are awarded throughout.
-
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences Division
The Nikon Small World competition, often.
Leave a Comment